179 related articles for article (PubMed ID: 37354683)
1. IMPACT OF THE ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS ON THE COURSE OF THE SEPTIC SHOCK DEVELOPED DURING COVID-19 AND OTHER SEVERE RESPIRATORY INFECTIONS IN PRESENCE OF HYPERFERRITINEMIA.
Rurua M; Ratiani L; Sanikidze T; Machvariani K; Pachkoria E; Ormocadze G; Mikadze I; Didbaridze T
Georgian Med News; 2023 Apr; (337):110-117. PubMed ID: 37354683
[TBL] [Abstract][Full Text] [Related]
2. CORRELATIVE ASSOCIATION OF OXYGENATION AND SEPSIS PANELS WITH THE USE OF ACE2 INHIBITORS AND WITHOUT IT IN THE CONDITIONS OF SEPTIC SHOCK IN COVID-19-INFECTED AND NON-INFECTED PATIENTS (COHORT STUDY).
Rurua M; Sanikidze T; Machvariani K; Pachkoria E; Ormotsadze G; Intskirveli N; Mikadze I; Didbaridze T; Ratiani L
Georgian Med News; 2023; (340-341):249-253. PubMed ID: 37805906
[TBL] [Abstract][Full Text] [Related]
3. Impact of the Angiotensin-Converting Enzyme (ACE) Inhibitors on the Course of the Acute Respiratory Distress Syndrome (ARDS) Developed During COVID-19 and Other Severe Respiratory Infections Under Hyperferritinemia Conditions: A Cohort Study.
Rurua M; Pachkoria E; Sanikidze T; Machvariani K; Ormocadze G; Jomidava T; Dzidziguri D; Ratiani L
Clin Med Insights Circ Respir Pulm Med; 2023; 17():11795484231180391. PubMed ID: 37313301
[TBL] [Abstract][Full Text] [Related]
4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
5. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation.
Carpenter RM; Young MK; Petri WAO; Lyons GR; Gilchrist C; Carey RM; Petri WA
mSphere; 2022 Aug; 7(4):e0022022. PubMed ID: 35913134
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
Wang K; Gheblawi M; Nikhanj A; Munan M; MacIntyre E; O'Neil C; Poglitsch M; Colombo D; Del Nonno F; Kassiri Z; Sligl W; Oudit GY
Hypertension; 2022 Feb; 79(2):365-378. PubMed ID: 34844421
[TBL] [Abstract][Full Text] [Related]
7. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
[TBL] [Abstract][Full Text] [Related]
8. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock.
Wang H; Das S; Wieruszewski PM; Taji J; Bartlett B; Azad N; Chowdhury A; Kolar GJ; Jain N; Subla MR; Khan SA
Chest; 2020 Aug; 158(2):e55-e58. PubMed ID: 32335068
[TBL] [Abstract][Full Text] [Related]
9. The value of sepsis biomarkers and their kinetics in the prognosis of septic shock due to bacterial infections.
Bahloul M; Bradii S; Turki M; Bouchaala K; Ben Hamida C; Chelly H; Ayedi F; Bouaziz M
Anaesthesiol Intensive Ther; 2021; 53(4):312-318. PubMed ID: 35257563
[TBL] [Abstract][Full Text] [Related]
10. The systemic renin-angiotensin system in COVID-19.
Reindl-Schwaighofer R; Hödlmoser S; Domenig O; Krenn K; Eskandary F; Krenn S; Schörgenhofer C; Rumpf B; Karolyi M; Traugott MT; Abrahamowicz A; Tinhof V; Mayfurth H; Rathkolb V; Mußnig S; Schmölz L; Ullrich R; Heinzel A; König F; Binder C; Bonderman D; Strassl R; Puchhammer-Stöckl E; Gorkiewicz G; Aberle JH; Jilma B; Wenisch C; Poglitsch M; Oberbauer R; Zoufaly A; Hecking M
Sci Rep; 2022 Nov; 12(1):20117. PubMed ID: 36418458
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Shukla AK; Banerjee M
High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
[TBL] [Abstract][Full Text] [Related]
12. Hyperferritinemia in Critically Ill Patients.
Lachmann G; Knaak C; Vorderwülbecke G; La Rosée P; Balzer F; Schenk T; Schuster FS; Nyvlt P; Janka G; Brunkhorst FM; Keh D; Spies C
Crit Care Med; 2020 Apr; 48(4):459-465. PubMed ID: 32205591
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptors: Impact for COVID-19 severity.
Aksoy H; Karadag AS; Wollina U
Dermatol Ther; 2020 Nov; 33(6):e13989. PubMed ID: 32645228
[TBL] [Abstract][Full Text] [Related]
14. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.
Karakaş Çelik S; Çakmak Genç G; Pişkin N; Açikgöz B; Altinsoy B; Kurucu İşsiz B; Dursun A
J Med Virol; 2021 Oct; 93(10):5947-5952. PubMed ID: 34170561
[TBL] [Abstract][Full Text] [Related]
16. The prognostic importance of the angiotensin II/angiotensin-(1-7) ratio in patients with SARS-CoV-2 infection.
Amezcua-Guerra LM; Del Valle L; González-Pacheco H; Springall R; Márquez-Velasco R; Massó F; Brianza-Padilla M; Manzur-Sandoval D; González-Flores J; García-Ávila C; Juárez-Vicuña Y; Sánchez-Muñoz F; Ballinas-Verdugo MA; Basilio-Gálvez E; Paez-Arenas A; Castillo-Salazar M; Cásares-Alvarado S; Hernández-Diazcouder A; Sánchez-Gloria JL; Tavera-Alonso C; Gopar-Nieto R; Sandoval J
Ther Adv Respir Dis; 2022; 16():17534666221122544. PubMed ID: 36082632
[TBL] [Abstract][Full Text] [Related]
17. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
[TBL] [Abstract][Full Text] [Related]
18. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
Verdecchia P; Cavallini C; Spanevello A; Angeli F
Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
[TBL] [Abstract][Full Text] [Related]
19. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.
Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H
FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370
[TBL] [Abstract][Full Text] [Related]
20. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
